Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prothena Corp Public (PRTA) Receivables (2016 - 2023)

Prothena Corp Public has reported Receivables over the past 10 years, most recently at $5.2 million for Q4 2023.

  • Quarterly results put Receivables at $5.2 million for Q4 2023, changed N/A from a year ago — trailing twelve months through Dec 2023 was $5.2 million (changed N/A YoY), and the annual figure for FY2023 was $5.2 million, changed.
  • Receivables for Q4 2023 was $5.2 million at Prothena Corp Public, roughly flat from $5.2 million in the prior quarter.
  • Over the last five years, Receivables for PRTA hit a ceiling of $5.2 million in Q3 2023 and a floor of $1000.0 in Q1 2021.
  • Median Receivables over the past 4 years was $56000.0 (2020), compared with a mean of $869923.1.
  • Biggest five-year swings in Receivables: surged 3300.0% in 2019 and later plummeted 99.43% in 2021.
  • Prothena Corp Public's Receivables stood at $68000.0 in 2019, then tumbled by 77.94% to $15000.0 in 2020, then surged by 426.67% to $79000.0 in 2021, then soared by 6430.38% to $5.2 million in 2023.
  • The last three reported values for Receivables were $5.2 million (Q4 2023), $5.2 million (Q3 2023), and $524000.0 (Q2 2023) per Business Quant data.